Vaccines are one of the world’s most cost-effective health tools, saving 3.5 to 5 million lives each year. We support the delivery of lifesaving vaccines to places with some of the highest rates of unimmunized children.
In July 2023, Revital Healthcare became the first-ever African manufacturer approved by the WHO to produce early activation auto-disable syringes—a milestone that will help diversify the geographic supplier base of…
The foundation has committed up to US$120 million to help ensure equitable global distribution of a promising new COVID-19 drug, molnupiravir. Here’s why that drug may be a game-changer in…
As the COVID-19 crisis continues, a well-coordinated global response is more important than ever. Drawing on insights from our broad array of partners, our foundation has identified a number of…
China’s achievement shows us that it’s possible to eliminate the disease worldwide. Innovative Chinese approaches may provide a successful formula for Africa, which has 90% of the global malaria burden.
The world must act quickly to support African institutions in fighting the third wave of COVID-19 and bringing vaccines to the more than 98 percent of Africans who remain unvaccinated.
Now is the time to support developing countries in building the infrastructure, skills, and systems they need to develop safe and affordable vaccines for diseases that mostly affect poorer nations.
In the race against the coronavirus and its variants, wealthier countries must meet their vaccine-sharing commitments faster and pledge a greater share of their supply to low- and middle-income countries.
